Personalized Medicine and Drug Development – Lauschke-lab

We integrate 3D cell culture systems of primary human cells, microfluidics and comprehensive molecular profiling technologies to discover novel therapeutic strategies for inflammatory conditions (NASH), infectious diseases (COVID-19 and hemorrhagic fevers) and complex metabolic diseases (type 2 diabetes).

Publications

Selected publications

All publications from group members

Staff and contact

Group leader

All members of the group